IBDEI1HK ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,26663,1,4,0)
 ;;=4^401.9
 ;;^UTILITY(U,$J,358.3,26663,2)
 ;;=^186630
 ;;^UTILITY(U,$J,358.3,26664,0)
 ;;=250.01^^158^1632^10
 ;;^UTILITY(U,$J,358.3,26664,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26664,1,3,0)
 ;;=3^DM Type I w/o Complications
 ;;^UTILITY(U,$J,358.3,26664,1,4,0)
 ;;=4^250.01
 ;;^UTILITY(U,$J,358.3,26664,2)
 ;;=^331780
 ;;^UTILITY(U,$J,358.3,26665,0)
 ;;=907.0^^158^1632^14
 ;;^UTILITY(U,$J,358.3,26665,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26665,1,3,0)
 ;;=3^Lt Eff Intracranial Inj
 ;;^UTILITY(U,$J,358.3,26665,1,4,0)
 ;;=4^907.0
 ;;^UTILITY(U,$J,358.3,26665,2)
 ;;=^68489
 ;;^UTILITY(U,$J,358.3,26666,0)
 ;;=438.9^^158^1632^13
 ;;^UTILITY(U,$J,358.3,26666,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26666,1,3,0)
 ;;=3^Lt Eff Cerebrovascular Disease,Unspec
 ;;^UTILITY(U,$J,358.3,26666,1,4,0)
 ;;=4^438.9
 ;;^UTILITY(U,$J,358.3,26666,2)
 ;;=^269757
 ;;^UTILITY(U,$J,358.3,26667,0)
 ;;=90732^^159^1633^6
 ;;^UTILITY(U,$J,358.3,26667,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26667,1,1,0)
 ;;=1^90732
 ;;^UTILITY(U,$J,358.3,26667,1,3,0)
 ;;=3^PNEUMOVAX
 ;;^UTILITY(U,$J,358.3,26668,0)
 ;;=86580^^159^1633^7
 ;;^UTILITY(U,$J,358.3,26668,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26668,1,1,0)
 ;;=1^86580
 ;;^UTILITY(U,$J,358.3,26668,1,3,0)
 ;;=3^PPD WITH CONTROLS
 ;;^UTILITY(U,$J,358.3,26669,0)
 ;;=90658^^159^1633^3^^^^1
 ;;^UTILITY(U,$J,358.3,26669,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26669,1,1,0)
 ;;=1^90658
 ;;^UTILITY(U,$J,358.3,26669,1,3,0)
 ;;=3^FLU VACCINE IM (FLULAVAL)
 ;;^UTILITY(U,$J,358.3,26670,0)
 ;;=90471^^159^1633^1^^^^1
 ;;^UTILITY(U,$J,358.3,26670,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26670,1,1,0)
 ;;=1^90471
 ;;^UTILITY(U,$J,358.3,26670,1,3,0)
 ;;=3^IMMUNIZATION ADMIN, SINGLE
 ;;^UTILITY(U,$J,358.3,26671,0)
 ;;=90472^^159^1633^2^^^^1
 ;;^UTILITY(U,$J,358.3,26671,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26671,1,1,0)
 ;;=1^90472
 ;;^UTILITY(U,$J,358.3,26671,1,3,0)
 ;;=3^IMMUNIZATION ADMIN, 2+
 ;;^UTILITY(U,$J,358.3,26672,0)
 ;;=86486^^159^1633^8^^^^1
 ;;^UTILITY(U,$J,358.3,26672,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26672,1,1,0)
 ;;=1^86486
 ;;^UTILITY(U,$J,358.3,26672,1,3,0)
 ;;=3^SKIN TEST, NOS ANTIGEN
 ;;^UTILITY(U,$J,358.3,26673,0)
 ;;=90656^^159^1633^4^^^^1
 ;;^UTILITY(U,$J,358.3,26673,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26673,1,1,0)
 ;;=1^90656
 ;;^UTILITY(U,$J,358.3,26673,1,3,0)
 ;;=3^FLU VACC SGL DOSE SYR (AFLURIA)
 ;;^UTILITY(U,$J,358.3,26674,0)
 ;;=90662^^159^1633^5^^^^1
 ;;^UTILITY(U,$J,358.3,26674,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26674,1,1,0)
 ;;=1^90662
 ;;^UTILITY(U,$J,358.3,26674,1,3,0)
 ;;=3^FLU VACC HIGH DOSE (FLUZONE)
 ;;^UTILITY(U,$J,358.3,26675,0)
 ;;=94642^^159^1634^3
 ;;^UTILITY(U,$J,358.3,26675,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26675,1,1,0)
 ;;=1^94642
 ;;^UTILITY(U,$J,358.3,26675,1,3,0)
 ;;=3^PENTAMIDINE THERAPY
 ;;^UTILITY(U,$J,358.3,26676,0)
 ;;=94664^^159^1634^1
 ;;^UTILITY(U,$J,358.3,26676,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26676,1,1,0)
 ;;=1^94664
 ;;^UTILITY(U,$J,358.3,26676,1,3,0)
 ;;=3^AEROSOL THERAPY
 ;;^UTILITY(U,$J,358.3,26677,0)
 ;;=89220^^159^1634^5^^^^1
 ;;^UTILITY(U,$J,358.3,26677,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26677,1,1,0)
 ;;=1^89220
 ;;^UTILITY(U,$J,358.3,26677,1,3,0)
 ;;=3^SPUTUM SPECIMEN COLLECT,AEROSOL
 ;;^UTILITY(U,$J,358.3,26678,0)
 ;;=94640^^159^1634^2^^^^1
 ;;^UTILITY(U,$J,358.3,26678,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26678,1,1,0)
 ;;=1^94640
 ;;^UTILITY(U,$J,358.3,26678,1,3,0)
 ;;=3^AIRWAY INHALATION TREATMENT
